PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of molvisLink to Publisher's site
 
Mol Vis. 2010; 16: 887–896.
Published online 2010 May 22.
PMCID: PMC2875257

A novel human CRYGD mutation in a juvenile autosomal dominant cataract

Abstract

Purpose

Identification of causal mutation in the crystallin, connexin, and paired box gene 6 (PAX6) genes associated with childhood cataract in patients from India.

Methods

In this study, forty eight members from seventeen families and 148 sporadic cases of childhood cataract were evaluated. Clinical and ophthalmologic examinations were performed on available affected and unaffected family members. Samples of genomic DNA were PCR amplified to screen for mutations in the candidate genes viz., alpha-A crystallin (CRYAA), beta- B2 crystallin (CRYBB2), gamma-A crystallin (CRYGA), gamma-B crystallin (CRYGB), gamma-C crystallin (CRYGC), gamma-D crystallin (CRYGD), gap junction alpha-3 (GJA3), gap junction alpha-8 (GJA8), and PAX6 based on polymerase chain reaction and single strand conformation polymorphism (PCR-SSCP) analysis. Samples showing any band mobility shift were subjected to bidirectional sequencing to confirm the variation. Co-segregation of the observed change with the disease phenotype was further tested by restriction fragment length polymorphism (RFLP) for the appropriate restriction site.

Results

DNA sequencing analysis of CRYAA, CRYBB2, CRYGA-D, GJA3, GJA8, and PAX6 of the affected members of a family (C-35) showed a novel heterozygous missense mutation C>A at position 229 in CRYGD in three affected members of family C-35 with anterior polar coronary cataract. This variation C229A substitution created a novel restriction site for AluI and resulted in a substitution of highly conserved arginine at position 77 by serine (R77S). AluI restriction site analysis confirmed the transversion mutation. Analysis of the available unaffected members of the family (C-35) and 100 unrelated control subjects (200 chromosomes) of the same ethnic background did not show R77S variation. Data generated using ProtScale and PyMOL programs revealed that the mutation altered the stability and solvent-accessibility of the CRYGD protein.

Conclusions

We describe here a family having anterior polar coronary cataract that co-segregates with the novel allele R77S of CRYGD in all the affected members. The same was found to be absent in the ethnically matched controls (n=100) studied. Interestingly the residue Arg has been frequently implicated in four missense (R15C, R15S, R37S, and R59H) and in one truncation mutation (R140X) of CRYGD. In two of the reported mutations Arg residues have been replaced with Serine. This finding further expands the mutation spectrum of CRYGD in association with childhood cataract and demonstrates a possible mechanism of cataractogenesis. Screening of other familial (n=48) and sporadic (n=148) cases of childhood cataract, did not reveal any previously reported or novel mutation in the candidate genes screened.

Introduction

Childhood cataract is the most common form of treatable blindness in children [1]. It accounts for more than 1 million blind children in Asia and about 10% of childhood blindness worldwide [2]. Non-syndromic congenital cataracts have an estimated incidence of 1–6 per 10,000 live births [3,4]. The prevalence of childhood cataract varies between different population, geographic area, socioeconomic condition and other factors. Etiologic factors include genetic, metabolic, systemic disorders, intrauterine infections, and trauma. Approximately 50% of the childhood cataracts are genetic and at least one-third may have the familial basis. It is both clinically and genetically diverse as demonstrated by several investigators suggesting involvement of possible modifying factors [2]. Hereditary cataracts typically follow Mendelian inheritance with majority being autosomal dominant type with complete penetrance and may be either static or progressive. Cataracts are classified based on morphology, location, or time of onset. Childhood cataracts have been mapped to 36 genetic loci and mutations in 22 genes have been identified toward the pathogenesis of various forms of congenital and developmental cataract including 12 loci for autosomal recessive cataract [5-8].

Biochemically up to 90% of the water soluble proteins in the vertebrate lens belong to α-, β-, and γ-crystallins. Being a part of small heat shock protein the α-crystallins form high-molecular aggregates and function as molecular chaperones. The β/γ-crystallin superfamily exhibits a characteristic Greek key motif, in a quadruple organization showing two in the NH2- and two in the COOH-terminal domain. Evolutionary analysis has demonstrated the relationship of crystallins to other stress proteins and is expressed in other tissues of the body as well [9].

The human gamma-crystallins (CRYG) gene cluster comprise six genes including two pseudogenes. The spectrum of mutations in CRYG gene leading to diverse cataract phenotypes is on the increase [10,11]. The aim of the present study therefore was to screen families with inherited cataracts to document known as well as novel mutations if any in human genes coding for alpha-A crystallin (CRYAA), beta-B2 crystallin (CRYBB2), gamma-crystallins (CRYG), gap junction alpha-3 and alpha-8 (GJA3, GJA8), and transcription factor paired box gene 6 (PAX6).

Methods

Cases of childhood cataract were registered through Kasturba Hospital (KH), Manipal, India. Clinical details of the proband were recorded in all the cases. Ophthalmic investigation included slit lamp examination with dilated pupils, visual acuity testing, intraocular pressure measurement, and fundus examination done by a senior ophthalmologist (V.P.). In familial cases, identification of cataract phenotype and detailed examination of the affected as well as available unaffected family members were performed. A detailed pedigree of the kindred was ascertained by interviewing the parents or any available family member. Clinical details of the patients who previously had cataract extraction were obtained through medical records. Cases presenting conditions such as unilateral, congenital rubella, systemic disorders, traumatic, syndromic, and other known causes were excluded for further study. Seeking of informed consent from all participants and parents of the probands was in accordance with the Declaration of Helsinki and Institutional Ethical Committee of Manipal University. Blood samples were collected from available affected/unaffected members of the family.

PCR and single stranded conformational polymorphism (SSCP) analysis

Genomic DNA was extracted from peripheral blood leukocytes using phenol chloroform method [12]. Exons and exon-intron boundaries of CRYAA, CRYBB2, CRYGA >D, GJA3, GJA8, and PAX6 were PCR amplified as per earlier reports on CRYAA [13], CRYBB2, GJA8 [14], CRYGA>D [15], GJA3 [16] and PAX6 [17]. The PCR reactions were performed at 94 °C for 4 min followed by 29 cycles at 94 °C for 30 s, at optimum annealing temperature for 45 s, at 72 °C extension for 45 s, and final extension for 10 min. Each reaction mix (25 µl) contained 50 ng of genomic DNA, 1× PCR buffer, 1.5 mM MgCl2, 200 µM dNTPs, 10 pmol each of sense and antisense primers (Table 1) and 1U of Taq DNA polymerase (Fermentas, Glen Burnie, MD). Thermal cycling was performed at suitable conditions using a VERITI 96 well thermal cycler (Applied Biosystems, Foster City, CA).

Table 1
List of primers used for PCR amplification of lens specific genes.

One affected member per family was screened for mutations in CRYAA, CRYBB2, CRYGA >D, GJA3, GJA8, and PAX6 by SSCP analysis of PCR products. PCR products were purified by QIA quick purification kit (Qiagen, Hilden, Germany). The amplicons were mixed with SSCP denaturation solution (95% formamide, 10 mM NaOH, 0.25% bromophenol blue, 0.25% Xylene Cyanol- all reagents from Sigma-Aldrich, St. Louis, MO), denatured at 95 °C for 5 min and snap cooled on ice. Denatured samples were subjected to SSCP using DCodeTM Universal Mutation Detection System (Bio-Rad Laboratories, Hercules, CA). The denatured samples were then electrophoresed at 400 V for 16 h at RT as well as at 12 °C on 8%–10% polyacrylamide gels. The gels were silver stained for visualization of bands [18]. Samples showing variation in mobility as band shifts were further processed for sequencing.

Restriction Fragment Length Polymorphism (RFLP)

RFLP analysis was performed using AluI restriction enzyme (New England Biolabs Ltd., NEB, Hitchin, Herts, UK) as per the manufacturer’s instructions in 10 µl volumes. The products were resolved on 2% agarose gel. The presence or absence of the AluI restriction site was checked in other family members and in 100 unrelated controls.

DNA sequencing and structure prediction

Samples showing mobility shift were subjected to direct sequencing using Big Dye terminator chemistry on an ABI 3130 genetic analyzer (Applied Biosystems). Sequencing reaction was run through a program which included 25 cycles of denaturation (96 °C for 10 s), annealing (50 °C for 5 s), and extension (60 °C for 4 min). Sequence data were analyzed by standard software and alignments done by ClustalW or BLAST (GenBank NM_006891). The prediction of protein structure was made by using PDB deep view or PyMOL programs.

Results

Clinical findings

The study was performed on patients with familial nonsyndromic bilateral childhood cataract. During the period (March 2004 to April 2009) forty eight subjects from 17 families and 148 isolated cases with childhood cataract were evaluated. Among these, zonular cataract was most frequent (46%), followed by total (13%) posterior sub capsular (10%), and nuclear cataracts (8%). Blue dot, sutural, and membranous cataracts were also recorded. In family C-35 (Figure 1A) the proband (III:1) underwent a surgery for cataract removal at the age of 11 years. Right eye showed the phenotype as anterior polar with coronary cataract and left eye with only anterior polar cataract with a progressive loss of vision. Other ocular examination showed normal ocular movements with clear cornea. Visual acuity was found to be 6/60 (RE) and 6/36 (LE). The proband’s younger sister (III:2) of age 9 years presented anterior polar cataract of progressive nature in both eyes. Visual acuity was 6/24 in both the eyes. The proband’s father (II:4) showed anterior polar cataract in both eyes. The youngest sister (III:3) of the proband and the mother when examined for visual acuity have normal vision with clear cornea. A typical example of a slit lamp image of patient III:1 (proband in family CAT-35) is shown in Figure 1B.

Figure 1
Pedigree of the C-35 family. A: The juvenile cataract affected family shows autosomal dominant mode of transmission with three affected individuals (II:4, III:1, and III:2). The arrow indicated the index case and the asterisk indicates members involved ...

Mutation analysis

All exons and intron/exon boundaries and flanking sequences of the candidate genes, CRYAA, CRYBB2, CRYGA>D, GJA3, GJA8, and PAX6 were screened by PCR-SSCP, RFLP, and DNA sequencing methods for detection of mutations. Consensus exon/intron boundaries in CRYAA, CRYBB2, CRYGA>D, GJA3, GJA8, and PAX6 were verified by gene-specific primers designed to anneal to intronic sequence flanking exon boundaries.

We have identified a sequence alteration in exon 2 of CRYGD in a proband (C-35) diagnosed to have anterior polar and coronary cataract using SSCP (Figure 2). The samples showing the differential migration patterns were subjected to DNA sequencing. Sequence analysis of the three exons and immediate flanking regions in three affected family members (II:4, III:1, and III:2) using specific primers detected a heterozygous C>A transversion in exon 2 resulting in a missense substitution of arginine to serine at codon 77 (R77S) which was not present in unaffected family member (II:3, II:5, and III:3; Figure 3). The observed sequence variation was also confirmed through sequencing with the reverse primer in all the family members.

Figure 2
PAGE showing differential migration of affected samples by the SSCP method. The affected individuals (III:1, III:2, and II:4) showed differential banding pattern with an extra band on 8% PAGE and unaffected (II:3, II:5, and III:3) showed normal banding ...
Figure 3
Genomic organization showing the region of R77S mutation. Electropherogram showing C>A heterozygous transversion in exon 2 CRYGD. The comparison of wild type and mutant sequences show c.229C>A substitution changes amino acid arginine to ...

This single-nucleotide change created an additional Alu1 restriction site in exon 2 of CRYGD. This Alu1 site (229AgkCT) co-segregated with affected individuals (II:4, III:1, and III:2) heterozygous for the R77S alteration (299, 196, 69, and 35 bp), but not in unaffected individuals (II:3, II:5; and III:3; 495, 69, and 35 bp) thus confirming the observed sequence variation and its segregation (Figure 4). We excluded this variation R77S of CRYGD as a single-nucleotide polymorphism in a panel of 100 normal unrelated subjects of the same ethnicity. Alignment of amino acid sequences of CRYGD as per the Entrez Protein database revealed that arginine at codon position 77 is phylogenetically conserved across species (Figure 5).

Figure 4
Restriction fragment length analysis of CRYGD exon 2. The mutation shows the gain of an Alu1 site (AGkCT) that co-segregated with affected individuals heterozygous for the C229A alteration (299,196, 69, and 35 bp), but not with unaffected individuals ...
Figure 5
Multiple sequence alignment of γD-crystallin protein in different species. Sequence alignment showing the phylogenetic conservation of arginine at amino acid position 77. The mutant sequence indicates the sequence with the mutation detected in ...

Taken overall, the co-segregation of R77S was seen only in affected members of the pedigree (C-35) and its absence in 200 normal chromosomes strongly suggest that the non-conservative R77S substitution might be a causative mutation rather than a benign polymorphism to be associated with the disease.

Sequencing of CRYGD gene in three affected (II:4, III:1, and III:2) and three unaffected individuals (II:3, II:5, and III:3) of C-35 family members showed four SNPs of which three (NG_008039.1:g.5277T>C; Y17Y; rs2242074, NG_008039.1:g.7677A>G; R95R; rs2305430, and NG_008039.1:g.7929T>C; rs2305429; 5′UTR) were reported earlier and a novel SNP E18F (NG_008039.1:g.5278G>A) was also observed. The inheritance of these five variations as a haplogroup in parents was analyzed (Table 2). It was found that the T-G-A-G-C haplogroup segregated with affected individuals showing transmission through paternal lineage.

Table 2
Haplotype analysis of SNPs/mutation found in CRYGD gene in C-35 family members.

Prediction of mutational change on protein properties

Both normal and mutant proteins were analyzed for their structure. The R77S (in the processed protein) is situated in second Greek key motif in the linker region as the last amino acid before start of the next beta sheet. The isoelectric point (pI) was found to be almost same for both wild type (7.0) and mutant (6.58) proteins. Molecular weight of the mutant (20,669 Da) protein was similar to that of wild-type protein (20,738 Da). There was an increase in hydrophobicity at the mutant site and its neighborhood (Figure 6).

Figure 6
Hydrophobicity profile of wild-type and R77S mutant γD-crystallin protein. Dotted circle represent the shift in the hydrophobicity around the mutant site. The prediction was done by ProtScale program at Expasy server.

The prediction of structural differences between wild-type and mutant proteins was performed using PyMOL tool. In the 3D model of human CRYGD protein (PDB code 1HK0), it was observed that the arginine side chain being longer protrudes out and might interact with the glutamic acid at position 46 forming ionic bonds. In the mutant form serine having a shorter side chain and being surrounded by valine and serine do not maintain the strong bonding with glu46 which may unfold the protein from its original folding. Arginine has well spread electron density enabling for high solubility. Moreover, the increased surface area in the arginine may facilitate better interaction with solvents, thereby reducing the solubility of mutant protein with substitution of serine without much change in kinase activity.

Discussion

Genes reported to cause cataract-specific mutations include those of the crystallins, cytoskeletal proteins, membrane proteins, transcription factors, glucosaminyl transferase 2 chromatin modifying protein-4B, and transmembrane protein 114 (TMEM114) [19]. Crystallin specific mutations account for 16.6% of inherited pediatric cataract in south India [20]. Among the reported genes, crystallins are of special interest because it encodes the major proportion of water soluble structural proteins of the lens fiber cells. In vertebrates, the α-, β-, and γ- crystallins are ubiquitous lens proteins. γ- Crystallin amounts for 25% of the total crystallins in the human lens. Both CRYGC and CRYGD are expressed at high concentrations in the fiber cells of the human embryonic lens which subsequently form the lens nucleus. The precise cellular micro-architecture and homeostasis are critical in maintaining the transparency of the lens. Alterations that impairs the proper solubility of lens proteins can lead to progressive protein aggregation that might act as light scattering centers in the lens [11].

Human γD-crystallin is a monomeric eye lens protein that must remain soluble throughout life for lens transparency. It is composed of two highly homologous beta-sheet domains which interact through interdomain side chain contacts forming two structurally distinct regions, a central hydrophobic cluster and peripheral residues. The specificity of domain interface interactions is likely important for preventing incorrect associations in the high protein concentrations of the lens nucleus [21]. Features of the interface between the two domains conserved among γ-crystallins are a central six-residue hydrophobic cluster, and two pairs of interacting residues flanking the cluster. In human γD-crystallin these pairs are Gln54/Gln143 and Arg79/Met147. It is suggested that these residues stabilize the native state by shielding the central hydrophobic cluster from solvent. In aged and cataractous lenses, glutamine and methionine side chains are among the residues covalently damaged. Such damage may generate partially unfolded, aggregation-prone conformations of human γD-crystallin that could be significant in cataract [22].

Many of the identified mutations in CRYGD seems to have been associated with autosomal dominant cataract phenotypes of congenital or juvenile nature. The eleven mutations identified so far occur as missense [10,15,23-34], nonsense [15,34-36], and as frameshift [37] to have been associated with diverse phenotypes (Table 3). Three of the truncation mutations and a frameshift mutation seem to be associated exclusively with nuclear phenotype and all are congenital [15,34-36]. The phenotype described here (C-35) is an anterior polar and coronary and the age at onset being within the first decade of life. As this mutation (R77S) involves the substitution of a highly basic and polar charged Arg for a less polar Ser residue it probably may not cause any major conformational change, as suggested earlier [32]. Along with the R77S mutation, four other variations as SNPs haplogroup show the transmission of T-G-A-G-C block from affected father to two affected children. The significance of this mutation, along with the prevalence of any specific haplotype, remains to be confirmed through analysis from a large number of familial cataracts. Predictions on structural changes in the mutant form of γD-crystallin using PyMOL reveals the shorter Ser side chain to establish weaker bonding with Glu46 that might result in unfolding. Furthermore, substitution with serine reduces the surface area of interaction with solvents thus hampering solubility of the mutant form as also revealed by increase in hydrophobicity (Figure 6). This may therefore be considered as the causative mutation underlying the cataract phenotype in the family (C-35) investigated. Interestingly four of the CRYGD mutant alleles reported earlier also involves the residue Arg at different codon positions viz., 15, 37, 59, and 140 . In our study, by sequence alignment, the observed variation involves an arginine residue at position 77 which is highly conserved in γD-crystallin across various other species. Among cataract specific CRYGD mutations, the Arg residue has been replaced either by cysteine [10,23], serine [28,29,32], Histidine [38], or for a stop codon [36]. Similar to the substitution in this study, the R37S mutation has been reported earlier to result in phenotypes with protein crystals in a Czech [28] and in a Chinese study [29]. Recently, in a Chinese family a corolliform cataract was found to be associated with an R15S allele of CRYGD [32]. It has been suggested that an increase in hydrophobicity and a putative phosphorylation site-mediated protein aggregation as the probable cause of opacification [32]. Both R15S and R37S results in congenital cataracts and fall within the I Greek key motif, while R77S falls within II Greek key motif and in association with a juvenile form of cataract in the C-35 family. Cataract-specific mutations involving the Arg residue has also been frequently reported in CRYAA [34,35]. This suggests that Arg residues are more critical toward maintaining the structural and functional integrity of proteins.

Table 3
Mutation spectrum of human CRYGD and cataract phenotypes in different childhood cataract families.

In the 16 other families studied no putative mutation could be observed in the candidate genes screened which therefore makes it rather unlikely that the selected genes are involved in the cataract-forming process in these families. It prompts screening of other known candidate genes. This demonstrates that cataract need not arise only through point mutations but might be influenced also by many other factors, which may include unidentified modifier genes and other sequence variations. Detailed information about such factors and their precise role should enable one to understand the pathophysiology of cataracts and the biology of the lens in general.

Acknowledgments

We are grateful to the family members for their participation in this study. This study was financially supported by Department of Biotechnology, Government of India under Indo-German Co-operation (BT/IN/FRG/JRS/2003-’04) and TIFAC-CORE in Pharmacogenomics, Department of Science and Technology, Government of India.

References

1. Gralek M, Kanigowska K, Seroczynska M. Cataract in children - not only an ophthalmological problem. Med Wieku Rozwoj. 2007;11:227–30. [PubMed]
2. Francis PJ, Berry V, Bhattacharya SS, Moore AT. The genetics of childhood cataract. J Med Genet. 2000;37:481–8. [PMC free article] [PubMed]
3. Foster A, Gilbert C, Rahi J. Epidemiology of cataract in childhood: a global perspective. J Cataract Refract Surg. 1997;23:601–4. [PubMed]
4. Dandona L, Williams JD, Williams BC, Rao GN. Population-based assessment of childhood blindness in Southern India. Arch Ophthalmol. 1998;116:545–6. [PubMed]
5. Zhang S, Liu M, Dong JM, Yin K, Wang P, Bu J, Li J, Hao YS, Hao P, Wang QK, Wang L. Identification of a genetic locus for autosomal dominant infantile cataract on chromosome 20p12.1-p11.23 in a Chinese family. Mol Vis. 2008;14:1893–7. [PMC free article] [PubMed]
6. Sajjad N, Goebel I, Kakar N, Cheema AM, Kubisch C, Ahmad J. A novel HSF4 gene mutation (p.R405X) causing autosomal recessive congenital cataracts in a large consanguineous family from Pakistan. BMC Med Genet. 2008;9:99. [PMC free article] [PubMed]
7. Litt M, Carrero-Valenzuela R, LaMorticella DM, Schultz DW, Mitchell TN, Kramer P, Maumenee IH. Autosomal dominant cerulean cataract is associated with a chain termination mutation in the human beta-crystallin gene CRYBB2. Hum Mol Genet. 1997;6:665–8. [PubMed]
8. Safieh LA, Khan AO, Alkuraya FS. Identification of a novel CRYAB mutation associated with autosomal recessive juvenile cataract in a Saudi family. Mol Vis. 2009;15:980–4. [PMC free article] [PubMed]
9. Graw J. Genetics of crystallins: Cataract and beyond. Exp Eye Res. 2009;88:173–89. [PubMed]
10. Stephan DA, Gillanders E, Vanderveen D, Freas-Lutz D, Wistow G, Baxevanis AD, Robbins CM, van Auken A, Quesenberry MI, Bailey-Wilson J, Juo SH, Trent JM, Smith L, Brownstein MJ. Progressive juvenile-onset punctate cataracts caused by mutation of the gD-crystallin gene. Proc Natl Acad Sci USA. 1999;96:1008–12. [PubMed]
11. Hejtmancik JF. Congenital cataracts and their molecular genetics. Semin Cell Dev Biol. 2008;19:134–49. [PMC free article] [PubMed]
12. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215. [PMC free article] [PubMed]
13. Graw J, Klopp N, Illig T, Preising MN, Lorenz B. Congenital cataract and macular hypoplasia in humans associated with a de novo mutation in CRYAA and compound heterozygous mutations in P. Graefes Arch Clin Exp Ophthalmol. 2006;244:912–9. [PubMed]
14. Santhiya ST, Manisastry SM, Rawlley D, Malathi R, Anishetty S, Gopinath PM, Vijayalakshmi P, Namperumalsamy P, Adamski J, Graw J. Mutation analysis of congenital cataracts in Indian families: identification of SNPs and a new causative allele in CRYBB2 gene. Invest Ophthalmol Vis Sci. 2004;45:3599–607. [PubMed]
15. Santhiya ST, Shyam Manohar M, Rawlley D, Vijayalakshmi P, Namperumalsamy P, Gopinath PM, Loster J, Graw J. Novel mutations in the gamma-crystallin genes cause autosomal dominant congenital cataracts. J Med Genet. 2002;39:352–8. [PMC free article] [PubMed]
16. Jiang H, Jin Y, Bu L, Zhang W, Liu J, Cui B, Kong X, Hu L. A novel mutation in GJA3 (connexin46) for autosomal dominant congenital nuclear pulverulent cataract. Mol Vis. 2003;9:579–83. [PubMed]
17. Glaser T, Walton DS, Maas RL. Genomic structure, evolutionary conservation and aniridia mutation in the human PAX6 gene. Nat Genet. 1992;2:232–9. [PubMed]
18. Bassam BJ, Caetano-Anolles G, Gresshoff PM. Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem. 1991;196:80–3. [PubMed]
19. Shiels A, Hejtmancik JF. Genetic origins of cataract. Arch Ophthalmol. 2007;125:165–73. [PubMed]
20. Devi RR, Yao W, Vijayalakshmi P, Sergeev YV, Sundaresan P, Hejtmancik JF. Crystallin gene mutations in Indian families with inherited pediatric cataract. Mol Vis. 2008;14:1157–70. [PMC free article] [PubMed]
21. Flaugh SL, Kosinski-Collins MS, King J. Contributions of hydrophobic domain interface Interactions to the folding and stability of human gammaD-crystallin. Protein Sci. 2005;14:569–81. [PubMed]
22. Flaugh SL, Kosinski-Collins MS, King J. Interdomain side chain interactions in human gammaD crystalline influencing folding and stability. Protein Sci. 2005;14:2030–43. [PubMed]
23. Gu F, Li R, Ma XX, Shi LS, Huang SZ, Ma X. A missense mutation in the gammaD-crystallin gene CRYGD associated with autosomal dominant congenital cataract in a Chinese family. Mol Vis. 2006;12:26–31. [PubMed]
24. Nandrot E, Slingsby C, Basak A, Cherif-Chefchaouni M, Benazzouz B, Hajaji Y, Boutayeb S, Gribouval O, Arbogast L, Berraho A, Abitbol M, Hilal L. Gamma-D crystallin gene (CRYGD) mutation causes autosomal dominant congenital cerulean cataracts. J Med Genet. 2003;40:262–7. [PMC free article] [PubMed]
25. Mackay DS, Andley UP, Shiels A. A missense mutation in the gammaD crystallin gene (CRYGD) associated with autosomal dominant “coral-like” cataract linked to chromosome 2q. Mol Vis. 2004;10:155–62. [PubMed]
26. Burdon KP, Wirth MG, Mackey DA, Russell-Eggitt IM, Craig JE, Elder JE, Dickinson JL, Sale MM. Investigation of crystallin genes in familial cataract, and report of two disease associated mutations. Br J Ophthalmol. 2004;88:79–83. [PMC free article] [PubMed]
27. Shentu X, Yao K, Xu W, Zheng S, Hu S, Gong X. Special fasciculiform cataract caused by a mutation in the gammaD-crystallin gene. Mol Vis. 2004;10:233–9. [PubMed]
28. Kmoch S, Brynda J, Asfaw B, Bezouska K, Novák P, Rezácová P, Ondrová L, Filipec M, Sedlácek J, Elleder M. Link between a novel human γD-crystallin allele and a unique cataract phenotype explained by protein crystallography. Hum Mol Genet. 2000;9:1779–86. [PubMed]
29. Gu J, Qi Y, Wang L, Wang J, Shi L, Lin H, Li X, Su H, Huang S. A new congenital nuclear cataract caused by a missense mutation in the gammD-crystallin gene (CRYGD) in a Chinese family. Mol Vis. 2005;11:971–6. [PubMed]
30. Li F, Wang S, Gao C, Liu S, Zhao B, Zhang M, Huang S, Zhu S, Ma X. Mutation G61C in the CRYGD gene causing autosomal dominant congenital coralliform cataracts. Mol Vis. 2008;14:378–86. [PMC free article] [PubMed]
31. Messina-Baas OM, Gonzalez-Huerta LM, Cuevas-Covarrubias SA. Two affected siblings with nuclear cataract associated with a novel missense mutation in the CRYGD gene. Mol Vis. 2006;12:995–1000. [PubMed]
32. Zhang LY, Gong B, Tong JP, Fan DS, Chiang SW, Lou D, Lam DS, Yam GH, Pang CP. A novel gammaD-crystallin mutation causes mild changes in protein properties but leads to congenital coralliform cataract. Mol Vis. 2009;15:1521–9. [PMC free article] [PubMed]
33. Khan AO, Aldahmesh MA, Ghadhfan FE, Al-Mesfer S, Alkuraya FS. Founder heterozygous P23T CRYGD mutation associated with cerulean (and coralliform) cataract in 2 Saudi families. Mol Vis. 2009;15:1407–11. [PMC free article] [PubMed]
34. Santana A, Waiswol M, Arcieri ES, Cabral de Vasconcellos JP, Barbosa de Melo M. Mutation analysis of CRYAA, CRYGC, and CRYGD associated with autosomal dominant congenital cataract in Brazilian families. Mol Vis. 2009;15:793–800. [PMC free article] [PubMed]
35. Hansen L, Yao W, Eiberg H, Kjaer KW, Baggesen K, Hejtmancik JF, Rosenberg T. Genetic heterogeneity in microcornea-cataract: five novel mutations in CRYAA, CRYGD, and GJA8. Invest Ophthalmol Vis Sci. 2007;48:3937–44. [PubMed]
36. Devi RR, Yao W, Vijayalakshmi P, Sergeev YV, Sundaresan P, Hejtmancik JF. Crystallin gene mutations in Indian families with inherited pediatric cataract. Mol Vis. 2008;14:1157–70. [PMC free article] [PubMed]
37. Zhang LY, Yam GH, Fan DS, Tam PO, Lam DS, Pang CP. A novel deletion variant of gammaD-crystallin responsible for congenital nuclear cataract. Mol Vis. 2007;13:2096–104. [PubMed]
38. Heon E, Priston M, Schorderet DF, Billingsley GD, Girard PO, Lubsen N, Munier FL. The γ-crystallins and human cataracts: a puzzle made clearer. Am J Hum Genet. 1999;65:1261–7. [PubMed]

Articles from Molecular Vision are provided here courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R. China